Our purpose
Improve people's lives
Therapeutic areas
Find out moreContract Manufacturing
Find out moreR&D
Find out morePatients
Find out moreAbout us
Learn how we've been delivering on our mission for patients for 90 years.
Media
ESTEVE CONSOLIDATES ITS DOUBLE-DIGIT GROWTH AND REACHES €710 MILLION IN NET INCOME
The company advances in its vision to be a leading international specialty pharmaceutical company, growing in Europe and expanding the portfolio
ESTEVE's medicine...
16/05/2024
Read moreESTEVE SIGNS A BINDING OFFER TO ACQUIRE HRA PHARMA RARE DISEASES, A PERRIGO COMPANY AFFILIATE
ESTEVE will increase its rare and severe diseases portfolio with three medicines addressing Cushing's syndrome and Adrenocortical Carcinoma.
This is a step forwar...
25/04/2024
Read moreJACOB TOLSTRUP, JOINS ESTEVE AS CHIEF BUSINESS DEVELOPMENT OFFICER
The new Chief Business Development Officer is focused on driving ESTEVE's growth to enhance value for people's lives.
08/04/2024
Read more